The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer

F Fontana, P Limonta - Free Radical Biology and Medicine, 2021 - Elsevier
Mitochondria are the cytoplasmic organelles mostly known as the “electric engine” of the
cells; however, they also play pivotal roles in different biological processes, such as cell …

Metformin: a promising antidiabetic medication for cancer treatment

W Mu, Y Jiang, G Liang, Y Feng, F Qu - Current Drug Targets, 2023 - ingentaconnect.com
Metformin is a widely used drug in patients with type 2 diabetes mellitus. Metformin inhibits
hepatic gluconeogenesis and increases glucose utilization in peripheral tissues. In recent …

[HTML][HTML] In Vivo and In Vitro Enhanced Tumoricidal Effects of Metformin, Active Vitamin D3, and 5-Fluorouracil Triple Therapy against Colon Cancer by Modulating the …

RA Almaimani, A Aslam, J Ahmad, MZ El-Readi… - Cancers, 2022 - mdpi.com
Simple Summary Failure of chemotherapy is common during the treatment of colon cancer,
and there is a compelling need to develop alternative therapeutic approaches against this …

[HTML][HTML] Mitochondrial sirtuins in chronic degenerative diseases: new metabolic targets in colorectal cancer

A Colloca, A Balestrieri, C Anastasio… - International Journal of …, 2022 - mdpi.com
Sirtuins (SIRTs) are a family of class III histone deacetylases (HDACs) consisting of seven
members, widely expressed in mammals. SIRTs mainly participate in metabolic …

[HTML][HTML] PROX1-mediated epigenetic silencing of SIRT3 contributes to proliferation and glucose metabolism in colorectal cancer

L Gan, Q Li, W Nie, Y Zhang, H Jiang… - … Journal of Biological …, 2023 - ncbi.nlm.nih.gov
Abstract Prospero-related homeobox 1 (PROX1) is a homeobox transcription factor known to
promote malignant transformation and stemness in human colorectal cancer (CRC) …

[HTML][HTML] SIRT3 and metabolic reprogramming mediate the antiproliferative effects of whey in human colon cancer cells

N D'Onofrio, E Martino, A Balestrieri, L Mele, G Neglia… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) is the second leading cause of cancer-related
deaths and the most frequently diagnosed cancer type. CRC risk can be preventable by …

[HTML][HTML] Dual anticancer role of metformin: an old drug regulating AMPK dependent/independent pathways in metabolic, oncogenic/tumorsuppresing and immunity …

MSM Marjanovic, LM Vucicevic… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Metformin has been known to treat type 2 diabetes for decades and is widely prescribed
antidiabetic drug. Recently, its anticancer potential has also been discovered. Moreover …

Metformin and thymoquinone co‐treatment enhance 5‐fluorouracil cytotoxicity by suppressing the PI3K/mTOR/HIF1α pathway and increasing oxidative stress in colon …

WF Farrash, A Aslam, R Almaimani, F Minshawi… - Biofactors, 2023 - Wiley Online Library
This study investigated the chemotherapeutic effects of 5‐fluorouracil (5‐FU), metformin
(Met), and/or thymoquinone (TQ) single/dual/triple therapies in the HT29, SW480 and …

[HTML][HTML] SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells

C Anastasio, I Donisi, V Del Vecchio, A Colloca… - Cellular & Molecular …, 2024 - Springer
Background Sodium-glucose transporter 2 (SGLT2) inhibitors (iSGLT2) are approved
medications for type 2 diabetes. Recent studies indicate that iSGLT2 inhibit the growth of …

Association of sirtuins (SIRT1-7) with lung and intestinal diseases

Y Chen, D Zhou, Y Feng, B Li, Y Cui, G Chen… - Molecular and Cellular …, 2022 - Springer
Abstract “Exterior-interior correlation between the lung and large intestine” is one of the
important contents of traditional Chinese medicine. This theory describes the role of the lung …